Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.
Mason JM, Chalmers JR, Godec T, Nunn AJ, Kirtschig G, Wojnarowska F, Childs M, Whitham D, Schmidt E, Harman K, Walton S, Chapman A, Williams HC; U.K. Dermatology Clinical Trials Network BLISTER Study Group. Mason JM, et al. Among authors: wojnarowska f. Br J Dermatol. 2018 Feb;178(2):415-423. doi: 10.1111/bjd.16006. Epub 2018 Jan 15. Br J Dermatol. 2018. PMID: 28940316 Free PMC article. Clinical Trial.
A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
Chalmers JR, Wojnarowska F, Kirtschig G, Mason J, Childs M, Whitham D, Harman K, Chapman A, Walton S, Schmidt E, Godec TR, Nunn AJ, Williams HC. Chalmers JR, et al. Among authors: wojnarowska f. Health Technol Assess. 2017 Mar;21(10):1-90. doi: 10.3310/hta21100. Health Technol Assess. 2017. PMID: 28406394 Free PMC article. Clinical Trial.
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.
Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, Chalmers JR, Childs M, Walton S, Harman K, Chapman A, Whitham D, Nunn AJ; UK Dermatology Clinical Trials Network BLISTER Study Group. Williams HC, et al. Among authors: wojnarowska f. Lancet. 2017 Apr 22;389(10079):1630-1638. doi: 10.1016/S0140-6736(17)30560-3. Epub 2017 Mar 6. Lancet. 2017. PMID: 28279484 Free PMC article. Clinical Trial.
Response to Letter by Prof. C.B.B. Bunker.
Kirtschig G, Becker K, Günthert A, Jasaitiene D, Cooper SM, Chi CC, Kreuter A, Rall KK, Aberer W, Riechardt S, Casabona F, Powell J, Brackenbury FA, Erdmann R, Lazzeri M, Barbagli G, Wojnarowska F. Kirtschig G, et al. Among authors: wojnarowska f. J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e104-e105. doi: 10.1111/jdv.13821. Epub 2016 Jul 12. J Eur Acad Dermatol Venereol. 2017. PMID: 27401731 No abstract available.
Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.
Kirtschig G, Cooper S, Aberer W, Günthert A, Becker K, Jasaitiene D, Chi CC, Kreuter A, Rall K, Riechardt S, Casabona F, Powell J, Brackenbury F, Erdmann R, Lazzeri M, Barbagli G, Wojnarowska F. Kirtschig G, et al. Among authors: wojnarowska f. J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e81-e83. doi: 10.1111/jdv.13740. Epub 2016 May 27. J Eur Acad Dermatol Venereol. 2017. PMID: 27229264 No abstract available.
Safety of topical corticosteroids in pregnancy.
Chi CC, Wang SH, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Chi CC, et al. Among authors: wojnarowska f. Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD007346. doi: 10.1002/14651858.CD007346.pub3. Cochrane Database Syst Rev. 2015. PMID: 26497573 Free PMC article. Review.
342 results